P723: Comparison of the Persistence Rates of Biologic Agents in Paediatric Crohn's Disease Patients (Japanese Paediatric IBD Registry Study)ECCO’23 CopenhagenYear: 2023
Authors: Nishida, D.(1);Ishige, T.(2);Arai, K.(3);Shimizu, H.(3);Iwama, I.(4);Nambu, R.(4);Kunisaki, R.(1);Yaguchi, K.(1)*;Mizuochi, T.(5);Murakoshi, T.(6);Saito, T.(7);Kato, S.(8);Kudo, T.(9);Iwata, N.(10);Inoue, M.(11);Yodoshi, T.(12);Hagiwara, S.I.(13);Toita, N.(14);Tajiri, H.(15);Mochizuki, T.(16);Kakuta, F.(17);Kumagai, H.(18);Noguchi, A.(19);Sasaki, M.(20);Nishimata, S.(21);Aomatsu, T.(22);Hirano, Y.(3);Shimizu, T.(23);
(1)Yokohama City University Medical Centre, Inflammatory Bowel Disease Centre, Yokohama, Japan;(2)Gunma University, Department of Paediatrics, Maebashi, Japan;(3)National Centre for Child Health and Development, Inflammatory Bowel Disease Centre, Tokyo, Japan;(4)Saitama Children's Medical Centre, Division of Gastroenterology and Hepatology, Saitama, Japan;(5)Kurume University, Department of Pediatrics and Child Health, Kurume, Japan;(6)Tokyo Metropolitan Children's Medical Centre, Department of Gastroenterology, Tokyo, Japan;(7)Chiba University, Department of Pediatric Surgery, Chiba, Japan;(8)Shinshu University, Department of Paediatrics, Matsumoto, Japan;(9)Juntendo University, Department of Paediatrics and Adolescent Medicine, Tokyo, Japan;(10)Aichi Children's Health and Medical Centre, Department of Infection and Immunology, Ohobu, Japan;(11)Mie University, Department of Gastrointestinal and Paediatric Surgery, Tsu, Japan;(12)Okinawa Chubu Hospital, Department of Paediatrics, Okinawa, Japan;(13)Osaka Women's and Children's Hospital, Department of Gastroenterology- Nutrition and Endocrinology, Izumi, Japan;(14)Sapporo Kosei General Hospital, Department of Paediatrics, Sapporo, Japan;(15)Osaka General Medical Centre, Department of Paediatrics, Osaka, Japan;(16)Osaka Police Hospital, Department of Pediatrics, Osaka, Japan;(17)Miyagi Children's Hospital, Department of General Paediatrics and Gastroenterology, Sendai, Japan;(18)Jichi Medical University, Department of Pediatrics, Shimotuke, Japan;(19)Akita University, Department of Paediatrics, Akita, Japan;(20)Iwate Medical University, Department of Paediatrics, Morioka, Japan;(21)Tokyo Medical University, Department of Paediatrics, Tokyo, Japan;(22)Osaka Medical University, Department of Paediatrics, Takatsuki, Japan;(23)Juntendo University, Department of Pediatrics and Adolescent Medicine, Tokyo, Japan;
P724: Upadacitinib is Effective and Safe in Tofacitinib-Experienced Patients with Ulcerative Colitis: A Prospective Real-World ExperienceECCO’23 CopenhagenYear: 2023
Authors: Krugliak Cleveland, N.(1)*;Friedberg, S.(1);Choi, D.(1);Hunold, T.(1);Choi, N.K.(1);Garcia, N.M.(1);Picker, E.A.(1);Cohen, N.A.(1);Cohen, R.D.(1);Dalal, S.R.(1);Pekow, J.(1);Sakuraba, A.(1);Rubin, D.T.(1);
(1)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;
P725: Patients with Immune Mediated Inflammatory Diseases are insufficiently protected against vaccine-preventable influenza and pneumococcal infections due to low vaccination ratesECCO’23 CopenhagenYear: 2023
Authors: Van De Pol, N.(1)*;van der Woude, C.J.(1);Vis, M.(2);van Doorn, M.B.A.(3);Derikx, L.A.A.P.(1);Molendijk, I.(1);de Vries, A.C.(1);
(1)Erasmus MC, Gastroenterology and hepatology, Rotterdam, The Netherlands;(2)Erasmus MC, Rheumatology, Rotterdam, The Netherlands;(3)Erasmus MC, Dermatology, Rotterdam, The Netherlands;
P726: Fecal calprotectin and quality of life questionnaires are responsive to change in pouch disease activity following antibiotic therapy—results from a prospective clinical trialECCO’23 CopenhagenYear: 2023
Authors: Ollech, J.(1)*;Yanai, H.(2);Avni Biron, I.(2);Dotan, I.(2);
(1)Rabin Medical Center, Gastroenterology, Petach Tikva, Israel;(2)Rabin Medical Center- Petah-Tikva- Israel- Sackler Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel, Gastroenterology, petah tikva, Israel;
P727: Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational StudiesECCO’23 CopenhagenYear: 2023
Authors: Macaluso, F.S.(1)*;Ventimiglia, M.(2);Orlando, A.(3);
(1)"Villa Sofia-Cervello” Hospital, IBD Unit, Palermo, Italy;(2)Italian Ministry of Health, Directorate General of Medical Device and Pharmaceutical Service- Italian Ministry of Health, Rome, Italy;(3)“Villa Sofia-Cervello” Hospital, IBD Unit, Palermo, Italy;
P729: Evaluation of hepatobiliary pathologies using transient elastography in patients with inflammatory bowel disease: What about the effect of drugs?ECCO’23 CopenhagenYear: 2023
Authors: Ağargün, B.F.(1);Şenkal, İ.V.(2);Rustamzade, A.(2);Nuriyev, K.(2);İstemihan, Z.(2);İmanov, Z.(2);Genç, S.(2);Çelik, B.(3);Şahutoğulları, D.(3);Çavuş, B.(2);Çifcibaşı Örmeci, A.(2);Demir, K.(2);Beşışık, S.F.(2);Kaymakoğlu, S.(2);Akyüz, F.(2)*;
(1)İstanbul Faculty of Medicine- İstanbul University, Department of Internal Medicine, Istanbul, Turkey;(2)İstanbul Faculty of Medicine- İstanbul University, Division of Gastroenterohepatology- Department of Internal Medicine, Istanbul, Turkey;(3)İstanbul Faculty of Medicine- İstanbul University, Faculty of Medicine, Istanbul, Turkey;
P730: Anti tumor necrosis factor treatment in Ulcerative Colitis: Real-world data and evaluation of current treatment targets (STRIDE II)ECCO’23 CopenhagenYear: 2023
Authors: Lundekvam, J.A.(1,2)*;Lie Høivik, M.(1,2);Anisdahl, K.(1,2);Cvancarova Småstuen, M.(3);Medhus, A.W.(1,2);
(1)Oslo University Hospital, Department of Gastroenterology, Oslo, Norway;(2)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(3)Oslo Metropolitan University, Department of Public Health, Oslo, Norway;Inflammatory Bowel Disease Research Group - Oslo University Hospital
P731: Effect on direct and indirect costs of switching Inflammatory Bowel Disease patients from intravenous to subcutaneous infliximab (CT-P13)ECCO’23 CopenhagenYear: 2023
Authors: Carbery, I.(1)*;Broglio, G.(2);Clark, T.(1);Greer, D.(1);Alakkari, A.(1);Selinger, C.P.(1);
(1)Leeds Teaching Hospitals Trust, Department of Gastroenterology, Leeds, United Kingdom;(2)IRCCS Fondazione Policlinico San Matteo, Internal Medicine, Pavia, Italy;
P732: Impact of different types of physical activity in inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Gofflot, A.(1)*;Monin, L.(2);Seidel, L.(3);Reenaers, C.(2);Kropp, S.(2);Van Kemseke, C.(2);Latour, P.(2);Forthomme, B.(1);Croisier, J.L.(1);Louis, E.(2);Vieujean, S.(2);
(1)University Hospital of Liege, Department of Physical Medicine and Rehabilitation, Liège, Belgium;(2)University Hospital of Liege, Hepato-Gastroenterology and Digestive Oncology, Liège, Belgium;(3)University Hospital of Liege, Department of Biostatistics and Medico-economic Information, Liège, Belgium;
P733: Novelties of COVID-19 vaccination beyond efficacy: Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patientsECCO’23 CopenhagenYear: 2023
Authors: Resál, T.(1)*;Horváth, M.(2);Bacsur, P.(1);Szántó, K.(1);Rutka, M.(1);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Fekete, J.(3);Miheller, P.(2);Molnár, T.(1);
(1)Szent-Györgyi Albert Medical School- University of Szeged, Department of Medicine, Szeged, Hungary;(2)Faculty of Medicine- Semmelweis University, Department of Surgery and Interventional Gastroenterology, Budapest, Hungary;(3)Semmelweis University, Department of Bioinformatics, Budapest, Hungary;
P734: A single measurement of fecal calprotectin, particularly if combined with hemoglobin and C-reactive protein levels, predicts Crohn's disease prognosis - a prospective studyECCO’23 CopenhagenYear: 2023
Authors: Magro, F.(1);Estevinho, M.M.(2)*;Catalano, G.(3);Patita, M.(4);Arroja, B.(5);Lago, P.(6);Rosa, I.(7);Tavares-de-Sousa, H.(8);Ministro, P.(9);Roseira, J.(8);Cancela, E.(9);Sousa, P.(9);Portela, F.(10);Correia, L.(11);Moreira, P.(12);Santiago, M.(13);Dias, S.(13);Afonso, J.(14);Danese, S.(15);Peyrin-Biroulet, L.(16);Dias, C.C.(17);
(1)Unit of Pharmacology and Therapeutics- Faculty of Medicine- University of Porto- Porto- Portugal., Department of Biomedicine-, Porto, Portugal;(2)Centro Hospitalar Vila Nova de Gaia/Espinho, Gastroenterology, Vila Nova de Gaia, Portugal;(3)Unit of Pharmacology and Therapeutics- Faculty of Medicine- University of Porto- Porto- Portugal, Biomedicine, Porto, Portugal;(4)Garcia da Orta Hospital- Almada- Portugal., Gastroenterology, Lisbon, Portugal;(5)Braga Hospital- Braga- Portugal., Gastroenterology, Braga, Portugal;(6)Porto Hospital University Centre- Porto- Portugal., Gastroenterology, Porto, Portugal;(7)IPOLFG- EPE- Lisbon- Portugal., Gastroenterology, Lisbon, Portugal;(8)Hospital Algarve, Gastroenterology, Portimão, Portugal;(9)Hospital Viseu, Gastroenterology, Viseu, Portugal;(10)Coimbra Hospital University Centre- Coimbra- Portugal., Gastroenterology, Coimbra, Portugal;(11)Northern Lisbon University Hospital Centre- Lisbon- Portugal, Gastroenterology, Lisbon, Portugal;(12)São João Hospital University Centre- Porto- Portugal., Clinical Pharmacology, Porto, Portugal;(13)Portuguese Group of Studies in Inflammatory Bowel Disease Grupo de Estudos da Doença Inflamatória Intestinal - GEDII- Portugal., a, Porto, Portugal;(14)Unit of Pharmacology and Therapeutics- Faculty of Medicine- University of Porto- Porto- Portugal., Biomedicine, Porto, Portugal;(15)IBD centre San Raffaelle, IBD centre, Milan, Italy;(16)Department of Gastroenterology and Inserm NGERE U1256- University Hospital of Nancy- University of Lorraine- Vandoeuvre-lès-- Nancy- France., Gastroenterology, Nancy, France;(17)Faculty of Medicine- University of Porto- Portugal., Information and Health Decision Sciences MEDCIDS-, Porto, Portugal;
P735: Real-life experience with the use of Tofacitinib in Colombian patients with moderate to severe Ulcerative Colitis: a descriptive study.ECCO’23 CopenhagenYear: 2023
Authors: Parra Izquierdo, L.V.(1)*;Frías-Ordoñez, J.(2); Márquez, J.R.(3);Juliao-Baños , F.(4);Galindo, P.(5);Cuadros, C.(6);Rojas, C.(7);Rojas, N.(7);Ardila, O.(8);Tovar-Fierro , G.(9);García-Duperly, R.(10);Gil Parada, F.L.(11);Imbeth Acosta, P.L.(12);Puentes, F.E.(13);Galiano de Sánchez, M.T.(14);Hani de Ardila, A.(15); Flórez-Sarmiento, C.(1);
(1)International Hospital of Colombia- Bucaramanga., Gastroenterology, Bucaramanga, Colombia;(2)National University of Colombia, Gastroenterology, Bogotá, Colombia;(3)Institute of Coloproctology- Las Américas Clinic- Medellín- Colombia, Gastroenterology, Medellin, Colombia;(4)Pablo Tobón Uribe Hospital- Medellín- Colombia, Gastroenterology, Medellin, Colombia;(5)Sebastián de Benalcázar Clinic- Cali- Colombia, Gastroenterology, Cali, Colombia;(6)International Hospital of Colombia- Bucaramanga., Pediatric Gastroenterology, Bucaramanga, Colombia;(7)Valle del Lili Foundation- Cali- Colombia, Gastroenterology, Cali, Colombia;(8)CES Clinic. Medellín- Colombia, Gastroenterology, Medellin, Colombia;(9)Carlos Ardila Lulle Foundation. Bucaramanga- Colombia., Gastroenterology, Bucaramanga, Colombia;(10)Santa Fe de Bogotá Foundation. Bogotá- Colombia, Coloproctology., Bogota, Colombia;(11)Colombia University Clinic- Bogotá., Gastroenterology and digestive endoscopy-, Bogota, Colombia;(12)Diagnosis and Therapeutics in Gastroenterology and Hepatology DITEG- Cartagena- Colombia, Gastroenterology, Cartagena, Colombia;(13)Unión de Cirujanos- Manizales- Caldas- Colombia, Gastroenterology, Manizales, Colombia;(14)Marly Clinic. Bogotá. Colombia, Gastroenterology, Bogota, Colombia;(15)Pontifical Xaverian University. Bogotá. Colombia, Gastroenterology, Bogota, Colombia;Colombian Crohn's and Colitis Study Group (GECCOL)
P736: Factors associated with partial Mayo Clinic Score over time in patients with Ulcerative Colitis treated with filgotinib in the phase 2b/3 SELECTION trialECCO’23 CopenhagenYear: 2023
Authors: Peyrin-Biroulet, L.(1)*;Louis , E.(2);Hisamatsu, T.(3);Jamoul, C.(4);Santermans, E.(4);Harris , K.(5);de Haas, A.(6);Oortwijn , A.(7);Feagan , B.(8);
(1)Hopitaux De Brabois, Department of Gastroenterology and Inserm U954, Vandoeuvre-Lès-Nancy, France;(2)University Hospital of Liège, Department of Gastroenterology, Liege, Belgium;(3)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Tokyo, Japan;(4)Galapagos NV, Biostatistics Department, Mechelen, Belgium;(5)Galapagos NV, Medical Evidence Generation Department, Milan, Italy;(6)Galapagos NV, Clinical Development Department, Leiden, The Netherlands;(7)Galapagos NV, Medical Affairs Department, Leiden, The Netherlands;(8)Western University, Division of Gastroenterology, London- ON, Canada;
P737: Intensification with intravenous ustekinumab in refractory Crohn´s diseaseECCO’23 CopenhagenYear: 2023
Authors: Arroyo Argüelles, J.M.(1);Suárez Ferrer, C.(2)*;Rueda García, J.L.(2);Martín-Arranz, E.(2);Poza Cordón, J.(2);Sánchez-Azofra, M.(2);García-Ramírez, L.(3);Martin-Arranz, M.D.(4);
(1)Hospital Universitario de Jaén, Gastroenterology Department. Hospital Universitario de Jaén- España., Jaén, Spain;(2)Grupo de enfermedades inmunomediadas gastrointestinales y otras patologías digestivas. Instituto de Investigación Sanitaria del Hospital Universitario La Paz – IdiPAZ- Madrid- España., Gastroenterology Department. Hospital Universitario La Paz- Madrid- Spain, Madrid, Spain;(3)Grupo de enfermedades inmunomediadas gastrointestinales y otras patologías digestivas. Instituto de Investigación Sanitaria del Hospital Universitario La Paz – IdiPAZ- Madrid- España., Fundación para la Investigación Biomédica- Hospital Universitario La Paz- Madrid- Spain, Madrid, Spain;(4)Grupo de enfermedades inmunomediadas gastrointestinales y otras patologías digestivas. Instituto de Investigación Sanitaria del Hospital Universitario La Paz – IdiPAZ- Madrid- España., Gastroenterology Department. Hospital Universitario La Paz- Madrid- Spain. Faculty of Medicine. Universidad Autónoma de Madrid, Madrid, Spain;
P738: Surgery for Crohn's Disease: Results from a Spanish cohort with 15 years of follow-upECCO’23 CopenhagenYear: 2023
Authors: Elosua Gonzalez, A.(1)*;Rubio, S.(2);Irisarri, R.(2);Campillo, A.(3);Nantes, Ó.(2);Vicuña, M.(2);Angós, R.(4);Zozaya, J.M.(2);Rodríguez, C.(2);
(1)Hospital García Orcoyen, Gastroenterology, Estella, Spain;(2)Hospital Universitario de Navarra, Gastroenterology, Pamplona, Spain;(3)Hospital Reina Sofía, Gastroenterology, Tudela, Spain;(4)Clínica Universidad de Navarra, Gastroenterology, Pamplona, Spain;
P739: Sequential treatment is effective to achieve remission and avoid colectomy in moderate-to-severe Ulcerative Colitis refractory to anti-TNF therapyECCO’23 CopenhagenYear: 2023
Authors: Farkas, B.(1)*;Borsos, M.(2);Resál, T.(1);Bacsur, P.(1);Bor, R.(1);Bálint, A.(1);Fábián, A.(1);Szepes, Z.(1);Molnár, T.(1);Farkas, K.(1);
(1)Albert Szent-Györgyi Medical School- University of Szeged, Department of Internal Medicine, Szeged, Hungary;(2)AdWare Research, Department of Biostatistics, Balatonfüred, Hungary;
P740: Dual biologic therapy for patients with Inflammatory Bowel Disease in a single reference center in SpainECCO’23 CopenhagenYear: 2023
Authors: Diz Lois Palomares, M.T.(1)*;Porta Sánchez, Á.(2);González Conde, B.(1);Estévez Prieto, E.(1);Vázquez Rey, M.T.(1);Elberdin Pazos, L.(2);Alonso Aguirre, P.(1);Martin Herranz, I.(2);
(1)A Coruña Universitary Hospital, Gastroenterology, A Coruña, Spain;(2)A Coruña Universitary Hospital, Pharmacy Department, A Coruña, Spain;
P742: Real-world evidence comparison on the effectiveness of ustekinumab vs anti-TNF or vedolizumab in ulcerative colitis: induction phase results from the prospective, observational RUN-UC studyECCO’23 CopenhagenYear: 2023
Authors: Bokemeyer, B.(1,2,3)*;Plachta-Danielzek, S.(2);Howaldt, S.(4);Mohl, W.(5);Efken, P.(6);Ehehalt, R.(7);Kahl, M.(8);Krause, T.(9);Trentmann, L.(10);Lügering, A.(11);Schnoy, E.(12);Jochum, C.(13);Fajardo Salmon, S.(2);Hartmann, P.(6);Gilman, E.(2);Schreiber, S.(2,3);
(1)Prof. Dr. Bernd Bokemeyer, Interdisciplinary Crohn Colitis Centre Minden, Minden, Germany;(2)Competence Network IBD, Study Department, Kiel, Germany;(3)University Hospital Schleswig-Holstein Campus Kiel, Clinic of General Internal Medicine I, Kiel, Germany;(4)Research Institut for IBD-HaFCED Hamburg, Gastroenterology Practice, Hamburg, Germany;(5)Center for Gastroenterology Saar MVZ, Gastroenmterology, Saarbruecken, Germany;(6)Gastroenterology Practice Minden, Gastroenterology, Minden, Germany;(7)Gastroenterology Practice Heidelberg, Gastroenterology, Heidelberg, Germany;(8)Gastroenterology Practice Hamburg, Gastroenterology, Hamburg, Germany;(9)Gastroenterology Practice Kassel, Gastroenterology, Kassel, Germany;(10)Gastroenterology Practice Bremen, Gastroenterology, Bremen, Germany;(11)Center for Gastroenterology Portal 10 Münster MVZ, Gastroenterology, Münster, Germany;(12)University Hospital Augsburg, III. Medical Clinic - Gastroenterology, Augsburg, Germany;(13)University Hospital Charite Berlin- Campus Mitte, Department of Hepatology and Gastroenterology, Berlin, Germany;
